1. Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?

   • Masanori Terashima

   Editorial 07 April 2016 Pages: 685 - 686

2. MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy

   • Hisato Kawakami
   • Isamu Okamoto

   Review Article 21 December 2015 Pages: 687 - 695

3. The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis

   • Emil ter Veer
   • Nadia Haj Mohammad
   • Hanneke W. M. van Laarhoven

   Review Article Open access 11 January 2016 Pages: 696 - 712

   

4. Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry

   • Anne Schlesinger-Raab
   • André L. Mihaljevic
   • Jutta Engel

   Original Article 11 August 2015 Pages: 713 - 722

   

5. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis

   • Sabrina M. Ebinger
   • René Warschkow
   • Marc Schiesser

   Original Article 21 September 2015 Pages: 723 - 734

   

6. Impact of being underweight on the long-term outcomes of patients with gastric cancer

   • Kazuhiro Migita
   • Tomoyoshi Takayama
   • Yoshiyuki Nakajima

   Original Article 23 August 2015 Pages: 735 - 743

   

7. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer

   • Hiroki Imaoka
   • Yuji Toiyama
   • Masato Kusunoki

   Original Article 02 August 2015 Pages: 744 - 753

   

8. CD97 promotion of gastric carcinoma lymphatic metastasis is exosome dependent

   • Daren Liu
   • Chao Li
   • Li Chen

   Original Article Open access 02 August 2015 Pages: 754 - 766

   

9. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas

   • Bo Gun Jang
   • Byung Lan Lee
   • Woo Ho Kim

   Original Article 19 September 2015 Pages: 767 - 777

   

10. MET overexpression and amplification define a distinct molecular subgroup for targeted therapies in gastric cancer

    • Yang Yang
    • Nandie Wu
    • Jia Wei

    Original Article 24 September 2015 Pages: 778 - 788

    

11. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients

    • Bolag Altan
    • Takehiko Yokobori
    • Hiroyuki Kuwano

    Original Article 15 October 2015 Pages: 789 - 797

    

12. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?

    • Hee Jin Kim
    • Nayoung Kim
    • Dong Ho Lee

    Original Article 07 October 2015 Pages: 798 - 807

    

13. Pepsinogen-II 100 bp ins/del gene polymorphism and its elevated circulating levels are associated with gastric cancer, particularly with Helicobacter pylori infection and intestinal metaplasia

    • Sushil Kumar
    • Niraj Kumari
    • Uday C. Ghoshal

    Original Article 20 October 2015 Pages: 808 - 816

    

14. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study

    • Jota Mikami
    • Yukinori Kurokawa
    • Yuichiro Doki

    Original Article 20 October 2015 Pages: 817 - 826

    

15. BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer

    • Tomohiro Kubo
    • Yutaka Kawano
    • Junji Kato

    Original Article 20 October 2015 Pages: 827 - 838

    

16. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)

    • Satoshi Matsusaka
    • Atsushi Nashimoto
    • Kazuhiro Yoshida

    Original Article Open access 12 August 2015 Pages: 839 - 851

    

17. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma

    • Byung-Hoon Min
    • Chung Hyun Tae
    • Kyoung-Mee Kim

    Original Article 12 August 2015 Pages: 852 - 859

    

18. Lymph node metastasis risk according to the depth of invasion in early gastric cancers confined to the mucosal layer

    • Young-Il Kim
    • Jun Ho Lee
    • Il Ju Choi

    Original Article 25 August 2015 Pages: 860 - 868

    

19. Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection?

    • Yong Hoon Kim
    • Jie-Hyun Kim
    • Seung Ho Choi

    Original Article 01 September 2015 Pages: 869 - 875

    

20. Development of an S-1 dosage formula based on renal function by a prospective pharmacokinetic study

    • Eisuke Booka
    • Chiyo K. Imamura
    • Yuko Kitagawa

    Original Article Open access 25 August 2015 Pages: 876 - 886

    

21. Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer

    • Tatiana Conrad
    • Steve MacLellan
    • Jolie Ringash

    Original Article 11 September 2015 Pages: 887 - 893

    

22. Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy

    • Hiroyuki Tabuse
    • Hiroya Kashiwagi
    • Hirofumi Yasui

    Original Article 11 September 2015 Pages: 894 - 901

    

23. Randomized phase II study of second-line chemotherapy with the best available 5-fluorouracil regimen versus weekly administration of paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407)

    • Tomohiro Nishina
    • Narikazu Boku
    • The Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group

    Original Article 19 September 2015 Pages: 902 - 910

    

24. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan

    • Genki Mori
    • Takeshi Nakajima
    • Ichiro Oda

    Original Article 29 September 2015 Pages: 911 - 918

    

25. Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer

    • Hideaki Bando
    • Yasuhide Yamada
    • Ichinosuke Hyodo

    Original Article 16 October 2015 Pages: 919 - 926

    

26. Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer

    • Kohei Shitara
    • Kei Muro
    • Atsushi Ohtsu

    Original Article 28 October 2015 Pages: 927 - 938

    

27. Comparison of laparoscopic versus open gastrectomy for advanced gastric cancer: an updated meta-analysis

    • Yingjun Quan
    • Ao Huang
    • Zhijun Min

    Original Article 28 July 2015 Pages: 939 - 950

    

28. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation

    • Ali Guner
    • Taeil Son
    • Woo Jin Hyung

    Original Article 01 August 2015 Pages: 951 - 960

    

29. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery

    • Norihiko Sugisawa
    • Masanori Tokunaga
    • Masanori Terashima

    Original Article 11 August 2015 Pages: 961 - 967

    

30. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)

    • Eiji Oki
    • Shoji Tokunaga
    • Kyushu Study Group of Clinical Cancer

    Original Article 11 August 2015 Pages: 968 - 976

    

31. Quality of life and nutritional consequences after aboral pouch reconstruction following total gastrectomy for gastric cancer: randomized controlled trial CCG1101

    • Yuichi Ito
    • Takaki Yoshikawa
    • Yasuhiro Kodera

    Original Article 14 August 2015 Pages: 977 - 985

    

32. Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy

    • Yasunari Fukuda
    • Kazuyoshi Yamamoto
    • Toshimasa Tsujinaka

    Original Article 25 September 2015 Pages: 986 - 993

    

33. To Roux or not to Roux: a comparison between Roux-en-Y and Billroth II reconstruction following partial gastrectomy for gastric cancer

    • Thuy B. Tran
    • David J. Worhunsky
    • George A. Poultsides

    Original Article 23 September 2015 Pages: 994 - 1001

    

34. Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis

    • Michitaka Honda
    • Naoki Hiki
    • Toshiharu Yamaguchi

    Original Article 07 October 2015 Pages: 1002 - 1007

    

35. Impact of preoperative hand grip strength on morbidity following gastric cancer surgery

    • Tsutomu Sato
    • Toru Aoyama
    • Takaki Yoshikawa

    Original Article 14 October 2015 Pages: 1008 - 1015

    

36. Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation

    • Nobutake Yamamichi
    • Chigaya Hirano
    • Kazuhiko Koike

    Short Communication 20 October 2015 Pages: 1016 - 1022

    

37. Role of age in association between gastric cancer and Helicobacter pylori eradication in cases with intestinal metaplasia and dysplasia

    • Ali Kabir

    Letter to the Editor 17 April 2015 Pages: 1023 - 1023

38. The adjacent to tumor sample trap

    • Paulo Pimentel de Assumpção
    • Sidney Emanuel Batista dos Santos
    • Rommel Mario Rodríguez Burbano

    Letter to the Editor 10 September 2015 Pages: 1024 - 1025

39. Erratum to: Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101)

    • Satoshi Matsusaka
    • Atsushi Nashimoto
    • Kazuhiro Yoshida

    Erratum 30 November 2015 Pages: 1026 - 1026